174 related articles for article (PubMed ID: 34461802)
1. Local recurrence and other oncologic outcomes after percutaneous image-guided tumor ablations on stageT1b renal cell carcinoma: a systematic review and network meta-analysis.
Cazalas G; Jambon E; Coussy A; Le Bras Y; Petitpierre F; Berhnard JC; Grenier N; Marcelin C
Int J Hyperthermia; 2021; 38(1):1295-1303. PubMed ID: 34461802
[TBL] [Abstract][Full Text] [Related]
2. A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study-UroCCR 80).
Cazalas G; Klein C; Piana G; De Kerviler E; Gangi A; Puech P; Nedelcu C; Grange R; Buy X; Jegonday MA; Bigot P; Bensalah CK; Gaillard V; Pignot G; Paparel P; Badet L; Michiels C; Bernhard JC; Rouviere O; Grenier N; Marcelin C
Eur Radiol; 2023 Sep; 33(9):6513-6521. PubMed ID: 37004570
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours.
Katsanos K; Mailli L; Krokidis M; McGrath A; Sabharwal T; Adam A
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):427-37. PubMed ID: 24482030
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety.
Guo J; Arellano RS
J Endourol; 2020 Oct; 34(10):1021-1027. PubMed ID: 32498630
[No Abstract] [Full Text] [Related]
7. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
8. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
Zhou W; Herwald SE; Uppot RN; Arellano RS
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity.
Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD
J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995
[TBL] [Abstract][Full Text] [Related]
11. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
12. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
13. An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma.
Wu J; Sami S; Lajkosz K; Kishibe T; Ordon M
J Endourol; 2023 Dec; 37(12):1314-1330. PubMed ID: 37819699
[No Abstract] [Full Text] [Related]
14. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
17. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Microwave Ablation for Malignant Renal Tumors: An Updated Systematic Review and Meta-Analysis of the Literature Since 2012.
Choi SH; Kim JW; Kim JH; Kim KW
Korean J Radiol; 2018; 19(5):938-949. PubMed ID: 30174484
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
[TBL] [Abstract][Full Text] [Related]
20. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
